Rheumatoid Arthritis News

Patients with rheumatoid arthritis who are Black are less likely to receive a biologic, and more likely to use glucocorticoids, than those who are white, according to a speaker at ACR Convergence 2020.

In this video, Jeffrey A. Sparks, MD, MMSc, associate physician at Brigham and Women’s Hospital, talked about adapting practice to telehealth during the COVID-19 pandemic.

In this video, Jeffrey A. Sparks, MD, MMSc, associate physician at Brigham and Women's Hospital, offered take home messages from a study focused on rheumatoid arthritis-associated interstitial lung disease, or RA-ILD, presented at ACR 2020.

Patients in the United States with rheumatoid arthritis made substantial changes to their medication use in the first 3 months of the COVID-19 pandemic, according to a speaker at ACR Convergence 2020.

In this video, Jeffrey A. Sparks, MD, MMSc, associate physician at Brigham and Women's Hospital, explained the findings from his study that investigated the relationship between rheumatoid arthritis and pulmonary function.

In this video, Jeffrey A. Sparks, MD, MMSc, associate physician at Brigham and Women's Hospital, spoke with Healio about a cross-sectional study presented at ACR 2020 that delved into the “lipid paradox.”

In this video, Dana DiRenzo, MD, MHS, instructor of medicine at Johns Hopkins, reviewed vaccine safety data and treatment response findings presented at ACR2020.

In this video, Jeffrey A. Sparks, MD, MMSc, associate physician at Brigham and Women's Hospital, highlighted data presented at ACR 2020 that investigated the incidence of dementia among patients with rheumatoid arthritis.

In this video, Dana DiRenzo, MD, MHS, instructor of medicine at Johns Hopkins, highlighted two important studies presented at ACR 2020.

Among patients using long-term glucocorticoids, denosumab is superior to alendronate in increasing bone mineral density in the spine after 1 year, according to a speaker at ACR Convergence 2020.